Last reviewed · How we verify
NCT03616041
Capsule Endoscopy for Severe Hematochezia
trial testing Second-generation colon capsule endoscopy system in Hematochezia in 23 participants. Currently enrolling.
30 October 2024
Quick facts
| Lead sponsor | CURE Digestive Diseases Research Center |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 23 |
| Start date | 10 February 2021 |
| Primary completion | 30 October 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Second-generation colon capsule endoscopy system
Conditions studied
- Hematochezia — all drugs for Hematochezia →
Sponsor
CURE Digestive Diseases Research Center
Who can join
18 and older, any sex, with Hematochezia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with severe hematochezia (bright red blood per rectum) may have a bleeding source proximal to the colon. Visualization of the entire gastrointestinal tract using a second-generation colon capsule endoscopy system could improve diagnostic yields and form the basis for a new approach to early diagnosis that could change guidelines and practice management in these patients. The hypothesis of this study is that urgent colon capsule endoscopy will have higher rates of lesion localization and diagnosis and reduced time to diagnosis than the standard tagged red blood cell scanning and/or angiography. In this study, the eligible patients with severe hematochezia are enrolled to undergo an evaluation with the capsule endoscopy in addition to the standard tests including a tagged RBC scan and/or an angiogram. The outcomes in terms of diagnostic yields of the capsule endoscopy will be compared to the standard tests.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03616041
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other CURE Digestive Diseases Research Center trials
Trials by the same sponsor.
- NCT03065465 — Standard Endoscopic Hemostasis Versus OVESCO Severe Non-variceal UGI Hemorrhage · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03616041 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CURE Digestive Diseases Research Center
- Last refreshed: 12 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03616041.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing